These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

4391 related items for PubMed ID: 6589433

  • 1. Correlation of cytotoxicity with elimination of iodine-125 from nude mice inoculated with prelabeled human melanoma cells.
    Lockshin A, Giovanella BC, Quian C, Mendoza JT, Vardeman DM, Stehlin JS.
    J Natl Cancer Inst; 1984 Aug; 73(2):417-22. PubMed ID: 6589433
    [Abstract] [Full Text] [Related]

  • 2. Effectiveness of anticancer drugs determined in nude mice inoculated with [125I]5-iodo-2'-deoxyuridine-prelabeled human melanoma cells.
    Lockshin A, Giovanella BC, Vardeman DM, Mendoza JT, Quian C, Kozielski T, Stehlin JS.
    J Natl Cancer Inst; 1985 Apr; 74(4):899-903. PubMed ID: 3921748
    [Abstract] [Full Text] [Related]

  • 3. In vivo cytotoxicity assays with 111In-labeled tumor cells: comparison with [125I]iododeoxyuridine-labeled cells and effects of chelators and inoculation site.
    Lockshin A, Kozielski T, Stehlin JS.
    Int J Rad Appl Instrum B; 1987 Apr; 14(5):515-21. PubMed ID: 3117739
    [Abstract] [Full Text] [Related]

  • 4. Determination of cytotoxicity in vivo using 111indium-labeled human tumor cells.
    Lockshin A, Giovanella BC, Kozielski T, Stehlin JS.
    Cancer Lett; 1984 Sep; 24(2):179-85. PubMed ID: 6434180
    [Abstract] [Full Text] [Related]

  • 5. Unlabelled iododeoxyuridine increases the rate of uptake of [125I]iododeoxyuridine in human xenografted glioblastomas.
    Dupertuis YM, Xiao WH, De Tribolet N, Pichard C, Slosman DO, Bischof Delaloye A, Buchegger F.
    Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):499-505. PubMed ID: 11914888
    [Abstract] [Full Text] [Related]

  • 6. Fluorodeoxyuridine improves imaging of human glioblastoma xenografts with radiolabeled iododeoxyuridine.
    Dupertuis YM, Vazquez M, Mach JP, De Tribolet N, Pichard C, Slosman DO, Buchegger F.
    Cancer Res; 2001 Nov 01; 61(21):7971-7. PubMed ID: 11691821
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Preclinical evaluation of locoregional delivery of radiolabeled iododeoxyuridine and thymidylate synthase inhibitor in a hepatoma model.
    Chi KH, Wang HE, Chen FD, Chao Y, Liu RS, Chou SL, Wang YS, Yen SH.
    J Nucl Med; 2001 Feb 01; 42(2):345-51. PubMed ID: 11216535
    [Abstract] [Full Text] [Related]

  • 9. Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice.
    Giavazzi R, Garofalo A, Bani MR, Abbate M, Ghezzi P, Boraschi D, Mantovani A, Dejana E.
    Cancer Res; 1990 Aug 01; 50(15):4771-5. PubMed ID: 2196116
    [Abstract] [Full Text] [Related]

  • 10. Isolation of mouse stromal cells associated with a human tumor using differential diphtheria toxin sensitivity.
    Arbiser JL, Raab G, Rohan RM, Paul S, Hirschi K, Flynn E, Price ER, Fisher DE, Cohen C, Klagsbrun M.
    Am J Pathol; 1999 Sep 01; 155(3):723-9. PubMed ID: 10487830
    [Abstract] [Full Text] [Related]

  • 11. Exceptional lethality for nude mice of cells derived from a primary human melanoma.
    Lockshin A, Giovanella BC, De Ipolyi PD, Williams LJ, Mendoza JT, Yim SO, Stehlin JS.
    Cancer Res; 1985 Jan 01; 45(1):345-50. PubMed ID: 3965144
    [Abstract] [Full Text] [Related]

  • 12. The preparation of clinical grade 5-[123I]iodo-2'-deoxyuridine and 5-[125I]iodo-2'-deoxyuridine with high in vitro stability and the potential for early proliferation scintigraphy.
    Schaffland AO, Delaloye AB, Kosinski M, Dupertuis YM, Buchegger F.
    Nucl Med Commun; 2004 May 01; 25(5):461-8. PubMed ID: 15100504
    [Abstract] [Full Text] [Related]

  • 13. Analysis of 5-iodo-2'-deoxyuridine incorporation in murine melanoma for photon activation therapy.
    Laster BH, Popenoe EA, Wielopolski L, Commerford SL, Gahbauer R, Goodman J, Meek A, Fairchild RG.
    Radiother Oncol; 1990 Oct 01; 19(2):169-78. PubMed ID: 2255770
    [Abstract] [Full Text] [Related]

  • 14. Radiolabeled alpha(v)beta3 integrin antagonists: a new class of tracers for tumor targeting.
    Haubner R, Wester HJ, Reuning U, Senekowitsch-Schmidtke R, Diefenbach B, Kessler H, Stöcklin G, Schwaiger M.
    J Nucl Med; 1999 Jun 01; 40(6):1061-71. PubMed ID: 10452325
    [Abstract] [Full Text] [Related]

  • 15. Biological behavior of malignant melanoma cells correlated to their survival in vivo.
    Fidler IJ.
    Cancer Res; 1975 Jan 01; 35(1):218-24. PubMed ID: 1109790
    [Abstract] [Full Text] [Related]

  • 16. Anti-transferrin receptor monoclonal antibody and toxin-antibody conjugates affect growth of human tumour cells.
    Trowbridge IS, Domingo DL.
    Nature; 1981 Nov 12; 294(5837):171-3. PubMed ID: 6272120
    [No Abstract] [Full Text] [Related]

  • 17. Lack of correlation between natural killer activity and tumor growth control in nude mice with different immune defects.
    Fodstad O, Hansen CT, Cannon GB, Statham CN, Lichtenstein GR, Boyd MR.
    Cancer Res; 1984 Oct 12; 44(10):4403-8. PubMed ID: 6467201
    [Abstract] [Full Text] [Related]

  • 18. Quantitative evaluation of anticancer agents against human melanoma cells implanted in nude mice.
    Lockshin A, Giovanella BC, Stehlin JS.
    Exp Cell Biol; 1986 Oct 12; 54(3):149-54. PubMed ID: 3743866
    [Abstract] [Full Text] [Related]

  • 19. 111Indium labeling of cultured human tumor cells.
    Lockshin A, Mendoza JT, Giovanella BC, Stehlin JS.
    Oncology; 1985 Oct 12; 42(5):322-7. PubMed ID: 3929199
    [Abstract] [Full Text] [Related]

  • 20. Heterogeneity in mouse seminal vesicle epithelial cells responding to androgen as evaluated by incorporation of [125I]iododeoxyuridine.
    Terada N, Ogasawara Y, Yamane T, Matsumoto K, Kitamura Y.
    Endocrinology; 1985 Apr 12; 116(4):1466-72. PubMed ID: 3971923
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 220.